Therapeutic Focus

Focused On Preventing or Reducing Drug and Disease-Induced Nausea & Vomiting

From a clinical standpoint, acute pain is the most common and demanding symptom to treat. Because the various forms of acute pain are so common, medical professionals are constantly seeking better ways to effectively treat patients.

Similar to pain, nausea and vomiting can be equally as difficult to endure. Unfortunately, they are prevalent side effects associated with drugs and conditions dominating the pain management markets. In 2015, IR hydrocodone, in combination with acetaminophen (APAP), was dispensed 97 million times in the US to treat pain. Two of the most common side effects of this treatment are nausea and vomiting.1

The research efforts of Charleston Laboratories are directed toward innovating in the global pain market. Charleston Laboratories’ novel product platform includes analgesics combined with anti-emetics at various strengths and routes of administration. Charleston Laboratories is also exploring abuse deterrent formulations — all of which are destined to shift the treatment paradigm in acute pain care.

Reference: 1. IMS Institute for Healthcare Informatics. Medicines Use and Spending in the U.S.: A Review of 2015 and Outlook to 2020. Parsippany, NJ: IMS Institute for Healthcare Informatics; 2016.